13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-05, with 30 holding rows worth $412,131,929.
- Accession
- 0000945621-24-000151
- Filer
- CIK 1475373
- Filed
- 2024-02-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 30 entries on the cover page, a total value of $412,131,929 stated on the cover page (in dollars after the unit check, H1), rows summing to $412,131,929 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Medtronic Plc | G5960L103 | COM | 435,075 | $35,841,479 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 1,093,416 | $31,479,447 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 382,362 | $30,975,146 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 102,234 | $26,455,092 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 398,699 | $25,034,310 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 374,687 | $19,225,190 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 247,531 | $19,139,097 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 219,000 | $17,292,240 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 141,218 | $17,186,231 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 164,305 | $16,561,944 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 216,416 | $16,060,231 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 193,279 | $14,606,094 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 187,556 | $14,301,145 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 27,807 | $13,112,669 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 328,132 | $12,685,583 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 234,374 | $12,489,790 | dollars as filed | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 50,686 | $11,520,421 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 127,312 | $9,354,886 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 86,247 | $8,315,936 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 190,539 | $8,275,109 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 23,609 | $7,623,110 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 145,012 | $7,336,157 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 32,092 | $6,142,730 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 188,111 | $5,889,755 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 40,592 | $5,652,030 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 200,000 | $5,548,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 102,490 | $4,901,072 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 39,876 | $4,389,151 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 52,316 | $3,243,592 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 148,538 | $1,494,292 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000945621-24-000151 | this filing | 2024-02-05 | acceptance time not in the bulk data set |